Resumen del estudio
objective and subjective sleep measures (p < 0.0001). Safety analyses indicated that mild adverse events occurred across all groups, with no clinically significant between-group differences. Overall, both Ashwagandha and melatonin improved sleep disturbances in adults, with combination therapy producing the most consistent and pronounced benefits. DOI: 10.3390/clockssleep8020015 PMCID: PMC13108063
Detalles bibliográficos
- Autores: Movva N, Salve J, Wankhede K, Thakare V, Langade D
- Publicado en: Clocks & sleep
- Fecha: 2026 Mar 27
- PMID: 42029558
- DOI: 10.3390/clockssleep8020015
📖 Leer el estudio completo en PubMed →
Esta evidencia se ha indexado automáticamente desde la base de datos PubMed (NCBI/NLM, US National Institutes of Health). El resumen mostrado es propiedad intelectual de sus autores y editorial.
